<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Damon987 - Latest News</title>
<link href="https://news.newswirebiz.com/rss/damon987/latest.xml"></link>
<updated>2026-07-21T12:34:27+00:00</updated>
<id>urn:uuid:fb1f6382-c523-1fb7-2d85-3195570e3478</id>
<entry>
<title>“HPAPI and Cytotoxic Drugs Manufacturing Market (3rd Edition), 2020-2030”</title>
<link href="https://news.newswirebiz.com/@damon987/hpapi-and-cytotoxic-drugs-manufacturing-market-3rd-edition-2020-2030-yd8jdjmwn8kp"></link>
<id>urn:uuid:69acd158-a885-615d-e6de-acd745371583</id>
<summary type="html"><![CDATA[A detailed review of the overall landscape of companies offering contract services for the manufacturing of HPAPIs and cytotoxic drugs]]></summary>
<updated>2021-04-14T08:02:25+00:00</updated>
</entry>
<entry>
<title>Close to 120 companies across the globe claim to possess the required expertise (Roots Analysis)</title>
<link href="https://news.newswirebiz.com/@damon987/close-to-120-companies-across-the-globe-claim-to-possess-the-required-expertise-roots-analysis-pj3nae7mq8xq"></link>
<id>urn:uuid:ce7b1110-3161-f6ff-38a1-71a92e551bf1</id>
<summary type="html"><![CDATA[Development initiatives of HPAPIs and cytotoxic drugs are generally very demanding, both in terms of experience and capital investment]]></summary>
<updated>2021-04-14T07:58:40+00:00</updated>
</entry>
<entry>
<title>The HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030</title>
<link href="https://news.newswirebiz.com/@damon987/the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-bw3pqdmrr8rp"></link>
<id>urn:uuid:c8ac2445-91b7-dbdf-6cbc-b91a988b18cc</id>
<summary type="html"><![CDATA[Roots Analysis has done a detailed study on “HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030”,]]></summary>
<updated>2021-04-14T07:56:14+00:00</updated>
</entry>
<entry>
<title>Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing (Roots Analysis)</title>
<link href="https://news.newswirebiz.com/@damon987/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-roots-analysis-6p3w7rkbd35y"></link>
<id>urn:uuid:f13dbf65-959b-d182-d535-4dcfb860c7c9</id>
<summary type="html"><![CDATA[Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers]]></summary>
<updated>2021-04-14T07:51:39+00:00</updated>
</entry>
<entry>
<title>“Oligonucleotide Synthesis, Modification and Purification Services Market”</title>
<link href="https://news.newswirebiz.com/@damon987/oligonucleotide-synthesis-modification-and-purification-services-market-b68qed7j78dj"></link>
<id>urn:uuid:b5c68120-d96b-03a2-f9e8-75a9f59d3162</id>
<summary type="html"><![CDATA[A detailed review of the current status of the market with respect to oligonucleotide manufacturers focused on research and diagnostic, and therapeutic applications.]]></summary>
<updated>2021-04-14T07:48:23+00:00</updated>
</entry>
<entry>
<title>More than 80 companies currently claim to offer manufacturing related services, at different scales of operations.</title>
<link href="https://news.newswirebiz.com/@damon987/more-than-80-companies-currently-claim-to-offer-manufacturing-related-services-at-different-scales-of-operations-6a35pb7qb8xd"></link>
<id>urn:uuid:c7f84023-33da-3668-a9f0-99f22d5671a8</id>
<summary type="html"><![CDATA[Several big pharma companies are known to outsource more than half of their clinical-stage oligonucleotide manufacturing operations. Anticipating a sharp rise in demand, oligonucleotide manufacturers are increasingly consolidating their portfolios]]></summary>
<updated>2021-04-14T07:44:57+00:00</updated>
</entry>
<entry>
<title>Modification and purification services market is projected to grow at an annualized rate of ~10%,</title>
<link href="https://news.newswirebiz.com/@damon987/modification-and-purification-services-market-is-projected-to-grow-at-an-annualized-rate-of-10-aw34bym5e354"></link>
<id>urn:uuid:2c3be50c-b576-e5ce-9d11-3ca91dbdbe2c</id>
<summary type="html"><![CDATA[Roots Analysis has done a detailed study on “Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030.””]]></summary>
<updated>2021-04-14T07:41:45+00:00</updated>
</entry>
<entry>
<title>The oligonucleotide synthesis market is estimated to be worth USD 5.8 billion in 2030,</title>
<link href="https://news.newswirebiz.com/@damon987/the-oligonucleotide-synthesis-market-is-estimated-to-be-worth-usd-58-billion-in-2030-nx8x7rajy3r7"></link>
<id>urn:uuid:e871010b-a6ee-00b1-7ef6-9611d5fcbd46</id>
<summary type="html"><![CDATA[The applications of oligonucleotides are vast, even beyond the life science / pharma sector; however, owing to complexities associated with the synthesis]]></summary>
<updated>2021-04-14T07:37:54+00:00</updated>
</entry>
<entry>
<title>‘Patient Recruitment and Retention Services, 2019-2030’ (Roots Analysis)</title>
<link href="https://news.newswirebiz.com/@damon987/patient-recruitment-and-retention-services-2019-2030-roots-analysis-b68qedb7w8dj"></link>
<id>urn:uuid:4c549f7a-ff12-73aa-dc0c-58e5108abd5f</id>
<summary type="html"><![CDATA[A detailed assessment of the current market landscape of companies offering patient recruitment and retention service]]></summary>
<updated>2021-04-07T11:15:49+00:00</updated>
</entry>
<entry>
<title>Close to 140 companies claim to be actively engaged in offering patient recruitment / retention services.</title>
<link href="https://news.newswirebiz.com/@damon987/close-to-140-companies-claim-to-be-actively-engaged-in-offering-patient-recruitment-retention-services-aw34byeyd354"></link>
<id>urn:uuid:58e46906-22a2-ea8d-8a75-375c41e449bd</id>
<summary type="html"><![CDATA[A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden]]></summary>
<updated>2021-04-07T11:12:46+00:00</updated>
</entry>
<entry>
<title>Patient recruitment and retention services market grow at an annualized rate of ~5%, (till 2030)</title>
<link href="https://news.newswirebiz.com/@damon987/patient-recruitment-and-retention-services-market-grow-at-an-annualized-rate-of-5-till-2030-nx8x7rdr63r7"></link>
<id>urn:uuid:848f9c8a-1043-e202-2a4f-e52768180f79</id>
<summary type="html"><![CDATA[resently, close to 140 companies claim to be actively engaged in offering patient recruitment / retention services to the pharmaceutical and medical devices industries, employing a variety of outreach methods and solutions]]></summary>
<updated>2021-04-07T11:09:34+00:00</updated>
</entry>
<entry>
<title>Patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030, (Roots Analysis)</title>
<link href="https://news.newswirebiz.com/@damon987/patient-recruitment-and-retention-services-market-is-estimated-to-be-worth-usd-53-billion-in-2030-roots-analysis-4n3babxbw8pq"></link>
<id>urn:uuid:f29b3cc4-92ff-eb2f-6585-e7c2ed3cdcfe</id>
<summary type="html"><![CDATA[Roots Analysis  is pleased to announce the publication of its recent study, titled, “Patient Recruitment and Retention Services Marker, 2019-2030.”]]></summary>
<updated>2021-04-07T11:06:21+00:00</updated>
</entry>
</feed>